Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Editas Medicine
(NQ:
EDIT
)
4.000
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Editas Medicine
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Editas Medicine Stock Is Jumping 13.9% This Week
June 25, 2021
The company received a go-ahead to enroll kids in a study of its lead gene-editing candidate.
Via
The Motley Fool
What's the Best Way to Invest in Genetics Stocks?
June 07, 2021
Here are some of our experts' favorite gene editing plays for the long run.
Via
The Motley Fool
Is Editas the Best Genetics Stock to Buy?
June 05, 2021
There are some big opportunities in the gene editing space.
Via
The Motley Fool
Earnings Roundup: General Motors, Editas Medicine, Activision Blizzard, Match Group
May 17, 2021
What we're learning during earnings season.
Via
The Motley Fool
Editas Medicine, Inc. (EDIT) Q1 2021 Earnings Call Transcript
May 05, 2021
EDIT earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
What Really Mattered With Editas Medicine's Q1 Update
May 05, 2021
It wasn't the biotech's financial performance.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021
May 04, 2021
Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,...
Via
Benzinga
Best Biotech Stocks & ETFs for mRNA, Gene Editing
April 29, 2021
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.
Via
Talk Markets
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 23, 2021
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 11.8% to $1.61 during Friday's pre-market session. The market value of their outstanding shares is at $205....
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 19, 2021
Gainers INmune Bio (NASDAQ:INMB) stock rose 26.18% to $13.59 during Monday's regular session. As of 08:06 EST, this security is trading at a volume of 560.6K shares,...
Via
Benzinga
CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today
April 16, 2021
A "sell" rating is one thing, but a 50% price target? It's no wonder Editas stock is crashing, and taking other gene-editing stocks with it.
Via
InvestorPlace
Nasdaq Stays Flat as Workhorse Drives Higher, Editas Sinks
April 16, 2021
Investors are trying to figure out which stocks have the best prospects.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
54 Biggest Movers From Friday
April 19, 2021
Gainers Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares surged 73.9% to close at $31.30 on Friday after the company priced its IPO at $18 per share. General Finance...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why Editas Medicine Stock Is Getting Crushed Today
April 16, 2021
Investors are running for the hills following this analyst take on the biotech's prospects.
Via
The Motley Fool
38 Stocks Moving In Friday's Mid-Day Session
April 16, 2021
Gainers Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares jumped 78.1% to $32.06 after the company priced its IPO at $18 per share. General Finance Corporation (NASDAQ: GFN)...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Benzinga's Top Ratings Upgrades, Downgrades For April 16, 2021
April 16, 2021
Upgrades According to Argus Research, the prior rating for United Airlines Holdings Inc (NASDAQ:UAL) was changed from Hold to Buy. In the fourth quarter, United Airlines...
Via
Benzinga
3 Biotech Stocks Ripe for Spring Portfolio Cleaning
April 16, 2021
All down 45% or more from their 52-week highs, should you consider cutting your losses?
Via
The Motley Fool
Biotech Stocks Hit A Snag — Why Experts Say The Heyday Isn't Over
April 09, 2021
Regulatory and drug-pricing worries have knocked biotech stocks off their pedestal. After hitting a high point in February, biotech stocks have fallen 20%.
Via
Investor's Business Daily
Exposures
COVID-19
Spring Cleaning for Investors
April 08, 2021
Start this year's spring cleaning by asking yourself the right questions.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.